Novo Nordisk's Wegovy weight-loss drug sales beat forecast, …
6 days ago · Wegovy Q3 sales total $2.5 bln. Beat forecast but group sales weaker than expected. Results soothe investor worries over slowing obesity drug demand. Shares rose nearly 9%, but later reversed ...
Novo Nordisk shares jump 8% after Wegovy sales beat …
Nov 6, 2024 · Novo Nordisk added that sales of Wegovy were 79% higher year-on-year in the third quarter, coming in at 17.3 billion Danish kroner. ... The news was taken as a signal that Novo Nordisk's efforts ...
Novo Nordisk Dominates Obesity Market as Wegovy Sales Soar …
6 days ago · Novo Nordisk (NYSE:NVO) is stealing the spotlight in the obesity drug market as Wegovy's sales skyrocketed by 76% year-over-year to DKK 38.3 billion, crushing analysts' forecasts. This explosive ...
Strong Wegovy revenue growth for Novo Nordisk but shares dip
6 days ago · Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same amount, totalling $10.6bn. The company narrowed its sales growth for the ...
Novo sees Wegovy sales rise as supply constraints ease
Nov 6, 2024 · Sales of Novo Nordisk’s obesity drug Wegovy were 81% higher in the third quarter of 2024 than the same period last year amid loosening supply constraints and broader insurance coverage, the company said Wednesday. Wegovy sales of 17.3 billion Danish kroner, or $2.5 billion, outpaced the $1.3 billion generated by Eli Lilly’s rival drug ...
Novo Nordisk CEO on Wegovy prices, supplies and compounding
LONDON, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its shares up nearly 9%. "In ...
Novo Nordisk's Blockbuster Wegovy Sales Beat Expectations — …
Nov 6, 2024 · Global News Select Novo Nordisk's Blockbuster Wegovy Sales Beat Expectations — Update ... The Danish pharmaceutical giant said sales of Wegovy surged 79% on year to 17.3 billion Danish kroner ...
Novo Nordisk's Blockbuster Wegovy Drug Sales Beat …
Nov 6, 2024 · Novo Nordisk's blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares 8.5% higher in early trade. Soaring popularity for its obesity drug has seen demand ...
Novo Nordisk lifts curbs on Wegovy prescriptions in the U.S., …
COPENHAGEN, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply in that market, its CEO said on ...
Wegovy sales are slaying for Novo Nordisk right now - Yahoo
6 days ago · Sales of the company’s weight loss drug Wegovy skyrocketed 79% to 17.3 billion Danish Krone ($2.5 billion) in the third-quarter of 2024, compared with in 9.6 billion Danish Krone ($1.37 billion ...
- Some results have been removed